|
市場調査レポート
商品コード
1404769
乳房再建の市場規模、シェア、動向分析レポート:製品別、形状別、最終用途別、地域別、セグメント予測、2024年~2030年Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implants, Tissue Expander), By Shape (Round, Anatomical), By End-use (Hospitals, ASCs), By Region, And Segment Forecasts, 2024 - 2030 |
||||||
カスタマイズ可能
|
乳房再建の市場規模、シェア、動向分析レポート:製品別、形状別、最終用途別、地域別、セグメント予測、2024年~2030年 |
出版日: 2023年11月27日
発行: Grand View Research
ページ情報: 英文 200 Pages
納期: 2~10営業日
|
Grand View Research, Inc.の最新レポートによると、世界の乳房再建市場規模は2024年から2030年にかけてCAGR 6.54%を記録し、2030年までに31億5,000万米ドルに達すると予測されています。
同市場は、乳がんの罹患率の高さ、再建手術件数の増加、乳房再建術の利用可能性に関する意識の高まりにより、大きな成長が見込まれています。乳がんは世界で最も罹患率の高いがんです。2022年の国際がん研究機関の発表によると、全世界で約2,261,419人の新規乳がん症例が記録され、同年の死亡者数は9,958,133人であった;同出典によると、この数は2025年までに7,790,717人に増加する見込みです。このように、乳がん患者数の増加に伴い、業界は今後数年間で成長すると予想されます。
新製品の発売、地理的拡大、パートナーシップ、大手企業による様々な戦略的イニシアティブも業界の成長を支えています。米国に本社を置く主要企業には、Allergan社(現在はAbbVie社の傘下)、Mentor社(Johnson &Johnson社の子会社)、Sientra社、Establishment Labs S.A.社、Ideal Implant Inc.社などがあります。この国には有力企業が存在するため、市場競争は激しいです。各社は業界の存在感を高めるために様々な取り組みを行っています。例えば、2023年6月、Sientra, Inc.はAlloX2 Pro Tissue ExpanderのFDA承認を取得しました。乳房再建手術の採用が増加していることは、美的向上のためのこれらの手術に関する女性の意識の高まりと相まって、マーケットの重要な起爆剤となっています。乳房再建手術は、乳房サイズの増大や乳房切除後の乳房再建のために女性が主に選択する手術であり、予測期間中の業界の成長を促進すると期待されています。
List of Figurs
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Breast Reconstruction Market revenue, 2018 - 2030 (USD Million)
Fig. 10 Breast Reconstruction Market snapshot
Fig. 11 Breast Reconstruction Market driver impact
Fig. 12 Breast Reconstruction Market restraint impact
Fig. 13 Porter's 5 Forces Analysis
Fig. 14 PESTEL Analysis
Fig. 15 Breast reconstruction market: Product movement analysis
Fig. 16 Segment dashboard
Fig. 17 Breast reconstruction market product outlook: Key takeaways
Fig. 18 Implants market, 2018 - 2030 (USD Million)
Fig. 19 Silicone breast implants market, 2018 - 2030 (USD Million)
Fig. 20 Saline breast implants market, 2018 - 2030 (USD Million)
Fig. 21 Tissue expander market, 2018 - 2030 (USD Million)
Fig. 22 Saline expander market, 2018 - 2030 (USD Million)
Fig. 23 Air tissue expander market, 2018 - 2030 (USD Million)
Fig. 24 Acellular dermal matrix market, 2018 - 2030 (USD Million)
Fig. 25 Breast reconstruction market shape outlook: Key takeaways
Fig. 26 Round shape market, 2018 - 2030 (USD Million)
Fig. 27 Anatomical shape market, 2018 - 2030 (USD Million)
Fig. 28 Breast reconstruction market end-use outlook: Key takeaways
Fig. 29 Hospitals market, 2018 - 2030 (USD Million)
Fig. 30 Cosmetology clinics market, 2018 - 2030 (USD Million)
Fig. 31 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
Fig. 32 Regional outlook, 2023 & 2030
Fig. 33 Regional market dashboard
Fig. 34 Regional marketplace: Key takeaways
Fig. 35 Breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 36 North America breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 37 US breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 38 Canada breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 39 Europe breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 40 UK breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 41 Germany breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 42 France breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 43 Italy breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 44 Spain breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 45 Denmark breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 46 Sweden breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 47 Norway breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 49 Japan breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 50 China breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 51 India breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 52 Australia breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 53 South Korea breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 54 Thailand breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 55 Latin America breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 56 Brazil breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 57 Mexico breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 58 Argentina breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 59 Middle East & Africa breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 60 South Africa breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 62 UAE breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 63 Kuwait breast reconstruction market, 2018 - 2030 (USD Million)
Fig. 64 Company market share analysis, 2023
Fig. 65 Market differentiators
Fig. 66 Regional network map
The global breast reconstruction market size is expected to reach USD 3.15 billion by 2030, registering a CAGR of 6.54% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is anticipated to witness significant growth due to the high incidence of breast cancer, increasing volume of reconstructive surgeries, and rising awareness regarding the availability of breast reconstruction procedures. Breast cancer is the most prevalent cancer worldwide. As per the International Agency for Research on Cancer in 2022, about 2,261,419 new breast cancer cases were recorded globally with 9,958,133 deaths in the same year; the same source stated that the number is expected to increase to 7,790,717 by 2025. Thus, with a rise in the number of breast cancer patients, the industry is expected to grow over the coming years.
New product launches, geographic expansions, partnerships, and various strategic initiatives undertaken by major players also support industry growth. Some of the key players, headquartered in the U.S., include Allergan (now part of AbbVie); Mentor (a subsidiary of Johnson & Johnson); Sientra, Establishment Labs S.A.; and Ideal Implant Inc. Due to the presence of leading players in this country, the market is highly competitive. Companies are undertaking various initiatives to strengthen their industry presence. For instance, in June 2023, Sientra, Inc. received FDA approval for its AlloX2 Pro Tissue Expander. Increasing adoption of breast reconstruction surgeries, combined with a growing awareness among women regarding these procedures for aesthetic enhancement, represents a significant catalyst for the market. Women predominantly opt for this surgery to augment breast size and reconstruct breasts following mastectomy, which is expected to fuel industry growth over the forecast period.